pili2002
2018-09-08
$Affimed Therapeutics(AFMD)$跌跌不休…
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":261706,"tweetId":"261706","gmtCreate":1536346420669,"gmtModify":1704772756663,"author":{"id":3494547626064968,"idStr":"3494547626064968","authorId":3494547626064968,"authorIdStr":"3494547626064968","name":"pili2002","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$Affimed Therapeutics(AFMD)$跌跌不休…</p></body></html>","htmlText":"<html><head></head><body><p>$Affimed Therapeutics(AFMD)$跌跌不休…</p></body></html>","text":"$Affimed Therapeutics(AFMD)$跌跌不休…","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/261706","repostId":0,"isVote":1,"tweetType":1,"viewCount":1404,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["AFMD"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":36,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/261706"}
精彩评论